A dual inhibitor of STAT3 pathways induces death of tumor cells [39], indicating that suppression of the JAK2/STAT3 pathway may be a promising approach for the prevention and treatment of pancreatic cancer. This evidence concerns the gene STAT3 and neoplasm.